IP Library Granted Patent US 12679835
Granted Patent B2
US 12679835 · App. 18/012,450 · Granted Jul 14, 2026

Benzothiazinone derivative substituted with trifluoromethyl at 6-position, and preparation method therefor and use thereof

Inventors: Chunhua Qiao (Suzhou, CN); Dongguang Fan (Suzhou, CN)
Assignee: SOOCHOW UNIVERSITY
C07D417/12A61K31/5415A61P31/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12679835
App. No.
18/012,450
Granted
Jul 14, 2026
Kind
B2
Abstract

A benzothiazinone derivative substituted with trifluoromethyl at 6-position, and a preparation method therefor and the use thereof. A series of compounds are obtained by means of changing the benzene ring of the benzothiazinone backbone, especially by means of changing a substituent thereof. Compared with other benzothiazinone derivatives, the benzothiazinone derivative substituted with trifluoromethyl at 6-position is more stable with regard to hepatic microsomal enzymes, and has longer metabolic half-life T 1/2 and better water solubility.

Claims (16)

1 . A 6-trifluoromethyl-substituted benzothiazinone derivative selected from the group consisting of:

wherein: R 1 is hydrogen, methyl or ethyl; R 2 is hydrogen, methyl or ethyl; and R 3 is hydrogen or halogen.

2 . The 6-trifluoromethyl-substituted benzothiazinone derivative according to claim 1 , selected from the group consisting of:

3 . A method of inhibiting tubercle bacillus in a subject, comprising:

administering to said subject a 6-trifluoromethyl-substituted benzothiazinone derivative according to claim 1 .

4 . A pharmaceutical composition comprising the 6-trifluoromethyl-substituted-benzothiazinone derivative according to claim 1 as an active ingredient.

5 . A method of preparing the 6-trifluoromethyl-substituted benzothiazinone derivative according to claim 1 , comprising: reacting a compound A5,

with an azide compound,

or reacting a compound A4,

with a compound BC,

or reacting the compound A4,

with a compound D2,

wherein: R 1 is hydrogen, methyl or ethyl; R 2 is hydrogen, methyl or ethyl; and R3 is hydrogen or halogen; X is O or S.

6 . The method according to claim 5 , wherein the reaction of the compound A5 and the azide compound is carried out at room temperature in the presence of a copper salt, a reducing agent and inorganic base; the reaction of compound A4 with the compound BC is carried out at room temperature; the reaction of compound A4 with compound D2 is carried out at room temperature.

7 . The method according to claim 5 , wherein the compound A4 is prepared by a process comprising: reacting compound A1,

with oxalyl chloride.